Company Form 4
Monopar Therapeutics (MNPR) Insider Trading Activity
Recent Form 4 filings for Monopar Therapeutics, grouped by transaction type, insider role, shares, value, and current-window signal.
Latest filing2026-09-28
Insider buys0
Insider sells4
Reported value$3.2M
Current Window Interpretation
Monopar Therapeutics has 6 Form 4 rows in the current 10-day generated window. The read is sale-heavy current window, with 0 buy rows, 4 sale rows, 0 grant rows, and $3.2M in reported transaction value.
Key Insider Activity
Largest buy N/A
No current-window buy row.
Largest sell $910,718
Robinson Chandler · 10,450 shares
Total shares 58,112
Across all current-window rows.
Latest Insider Transactions
Sorted by transaction date and reported value.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-242026-09-28 | Robinson ChandlerChief Executive Officer | Open-market sale | 10,450 | $910,718Price $87 |
| 2026-09-242026-09-28 | Robinson ChandlerChief Executive Officer | Open-market sale | 9,638 | $847,758Price $88 |
| 2026-09-242026-09-28 | Robinson ChandlerChief Executive Officer | Open-market sale | 8,368 | $744,501Price $89 |
| 2026-09-242026-09-28 | Robinson ChandlerChief Executive Officer | Open-market sale | 600 | $53,874Price $90 |
| 2026-09-242026-09-28 | Robinson ChandlerChief Executive Officer | Option exercise | 14,056 | $421,680Price $30 |
| 2026-09-242026-09-28 | Robinson ChandlerChief Executive Officer | Option exercise | 15,000 | $210,000Price $14 |